Ascorbic acid 120gm./ pack 1Sodium Chloride 124gm Trisodium citrate dihydrate 103gm Potassium Chloride 52gm Glucose (anhydrous) to 579gm. / pack 2 - hasil pencarian

sanofi-aventis australia pty ltd - chlorpromazine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; hypromellose; macrogol 200; magnesium stearate; titanium dioxide; purified water; industrial methylated spirit - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

largactil chlorpromazine hydrochloride 100mg tablet

clinect pty ltd - chlorpromazine hydrochloride, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; hypromellose; macrogol 200; magnesium stearate; titanium dioxide; purified water; industrial methylated spirit - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.